Back to Search
EDWIN HOLLER, MD
MD
Surgery Physician
NPI: 1336158286Individual
Specialties, Licenses & Credentials
Surgery PhysicianPrimary
Surgery
Code: 208600000X
9300154(NC)
Research & Publications (20)
Preventive usage of broad spectrum chemokine inhibitor NR58-3.14.3 reduces the severity of pulmonary and hepatic graft-versus-host disease.
PMID 19288173·Int J Hematol·2009
7-preclinical
The role of innate immunity in graft-versus-host disease and complications following allogeneic stem cell transplant.
PMID 19147080·Biol Blood Marrow Transplant·2009
6-review
The role of genetic variants of NOD2/CARD15, a receptor of the innate immune system, in GvHD and complications following related and unrelated donor haematopoietic stem cell transplantation.
PMID 18976442·Int J Immunogenet·2008
8-other
Influence of polymorphism within the heme oxygenase-I promoter on overall survival and transplantation-related mortality after allogeneic stem cell transplantation.
PMID 18804049·Biol Blood Marrow Transplant·2008
8-other
Pulmonary function changes in experimental graft-versus-host disease of the lung.
PMID 18721763·Biol Blood Marrow Transplant·2008
7-preclinical
Risk assessment in haematopoietic stem cell transplantation: GvHD prevention and treatment.
PMID 17448962·Best Pract Res Clin Haematol·2007
6-review
Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination.
PMID 16424393·Blood·2006
8-other
Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation.
PMID 15090455·Blood·2004
8-other
Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation.
PMID 10673693·Bone Marrow Transplant·2000
8-other
Chemokine and chemokine receptor expression analysis in target organs of acute graft-versus-host disease.
PMID 19571824·Genes Immun·2009
7-preclinical
Pharmaceutical and cellular strategies in prophylaxis and treatment of graft-versus-host disease.
PMID 19519437·Curr Pharm Des·2009
6-review
Pathophysiology and management of graft-versus-host disease in the era of reduced-intensity conditioning.
PMID 19561413·Curr Opin Oncol·2009
6-review
Bleeding events and mortality in SCT patients: a retrospective study of hematopoietic SCT patients with organ dysfunctions due to severe sepsis or GVHD.
PMID 19079317·Bone Marrow Transplant·2009
4-observational
The release of soluble factors contributing to endothelial activation and damage after hematopoietic stem cell transplantation is not limited to the allogeneic setting and involves several pathogenic mechanisms.
PMID 19361745·Biol Blood Marrow Transplant·2009
8-other
Regulatory T-cell suppression of CD8+ T-cell-mediated graft-versus-host reaction requires their presence during priming.
PMID 19623013·Transplantation·2009
8-other
Physarum polymalic acid hydrolase: Recombinant expression and enzyme activation.
PMID 18845127·Biochem Biophys Res Commun·2008
7-preclinical
Polymorphisms of cytokine and innate immunity genes and GVHD.
PMID 18503983·Best Pract Res Clin Haematol·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 500 E PARKER RD
MORGANTON, NC 28655 - Phone
- (828) 430-9566
Quick Facts
- NPI
- 1336158286
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile